2020 ESGO/SIOPE指南:青少年和年轻人非上皮性卵巢癌的管理

2020-07-02 欧洲妇科肿瘤学会 Lancet Oncol . 2020 Jul;21(7):e360-e368.

2020年7月,欧洲妇科肿瘤学会(ESGO)联合欧洲妇科肿瘤学会(ESGO)共同发布了青少年和年轻人非上皮性卵巢癌的管理指南。主要面向15-25岁的非上皮下卵巢癌患者,包括卵巢恶性生殖细胞瘤,性索间质

中文标题:

2020 ESGO/SIOPE指南:青少年和年轻人非上皮性卵巢癌的管理

英文标题:

ESGO-SIOPE Guidelines for the Management of Adolescents and Young Adults With Non-Epithelial Ovarian Cancers

发布机构:

欧洲妇科肿瘤学会

发布日期:

2020-07-02

简要介绍:

2020年7月,欧洲妇科肿瘤学会(ESGO)联合欧洲妇科肿瘤学会(ESGO)共同发布了青少年和年轻人非上皮性卵巢癌的管理指南。主要面向15-25岁的非上皮下卵巢癌患者,包括卵巢恶性生殖细胞瘤,性索间质瘤和高钙血症型卵巢小细胞癌。

相关资料下载:
[AttachmentFileName(sort=1, fileName=020 ESGO_SIOPE指南:青少年和年轻人非上皮性卵巢癌的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=65d851c00193216d, title=2020 ESGO/SIOPE指南:青少年和年轻人非上皮性卵巢癌的管理, enTitle=ESGO-SIOPE Guidelines for the Management of Adolescents and Young Adults With Non-Epithelial Ovarian Cancers, guiderFrom=Lancet Oncol . 2020 Jul;21(7):e360-e368., authorId=0, author=, summary=2020年7月,欧洲妇科肿瘤学会(ESGO)联合欧洲妇科肿瘤学会(ESGO)共同发布了青少年和年轻人非上皮性卵巢癌的管理指南。主要面向15-25岁的非上皮下卵巢癌患者,包括卵巢恶性生殖细胞瘤,性索间质, cover=https://img.medsci.cn/202079/1594232649890_2020535.jpg, journalId=0, articlesId=null, associationId=1422, associationName=欧洲妇科肿瘤学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jul 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年7月,欧洲妇科肿瘤学会(ESGO)联合欧洲妇科肿瘤学会(ESGO)共同发布了青少年和年轻人非上皮性卵巢癌的管理指南。主要面向15-25岁的非上皮下卵巢癌患者,包括卵巢恶性生殖细胞瘤,性索间质瘤和高钙血症型卵巢小细胞癌。</p> </div> </div> </div>, tagList=[TagDto(tagId=359, tagName=卵巢癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=359, guiderKeyword=卵巢癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4306, appHits=150, showAppHits=0, pcHits=962, showPcHits=4156, likes=4, shares=10, comments=5, approvalStatus=1, publishedTime=Thu Jul 09 02:32:03 CST 2020, publishedTimeString=2020-07-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 09 02:24:16 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 07:55:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=020 ESGO_SIOPE指南:青少年和年轻人非上皮性卵巢癌的管理.pdf)])
020 ESGO_SIOPE指南:青少年和年轻人非上皮性卵巢癌的管理.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1187871, encodeId=cb29118e8717f, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220125/a0f139e590b8459ab0818b4c8db10d1e/720e8522d6f0409e9b33c4b968b59898.jpg, createdBy=c3b64856317, createdName=muxiaoqin28, createdTime=Tue Jan 25 00:12:18 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068245, encodeId=6605106824536, content=好平台 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d1786606, createdName=ms8456386680208506, createdTime=Mon Nov 08 20:26:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058843, encodeId=71e210588433d, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfd85517072, createdName=ms3000001993774108, createdTime=Sat Oct 09 10:01:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897843, encodeId=a91289e84328, content=实用指南,值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9665433008, createdName=ms2000001443379879, createdTime=Sun Nov 08 23:14:12 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2022-01-25 muxiaoqin28

    有没有中文版的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1187871, encodeId=cb29118e8717f, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220125/a0f139e590b8459ab0818b4c8db10d1e/720e8522d6f0409e9b33c4b968b59898.jpg, createdBy=c3b64856317, createdName=muxiaoqin28, createdTime=Tue Jan 25 00:12:18 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068245, encodeId=6605106824536, content=好平台 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d1786606, createdName=ms8456386680208506, createdTime=Mon Nov 08 20:26:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058843, encodeId=71e210588433d, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfd85517072, createdName=ms3000001993774108, createdTime=Sat Oct 09 10:01:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897843, encodeId=a91289e84328, content=实用指南,值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9665433008, createdName=ms2000001443379879, createdTime=Sun Nov 08 23:14:12 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2021-11-08 ms8456386680208506

    好平台

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1187871, encodeId=cb29118e8717f, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220125/a0f139e590b8459ab0818b4c8db10d1e/720e8522d6f0409e9b33c4b968b59898.jpg, createdBy=c3b64856317, createdName=muxiaoqin28, createdTime=Tue Jan 25 00:12:18 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068245, encodeId=6605106824536, content=好平台 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d1786606, createdName=ms8456386680208506, createdTime=Mon Nov 08 20:26:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058843, encodeId=71e210588433d, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfd85517072, createdName=ms3000001993774108, createdTime=Sat Oct 09 10:01:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897843, encodeId=a91289e84328, content=实用指南,值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9665433008, createdName=ms2000001443379879, createdTime=Sun Nov 08 23:14:12 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2021-10-09 ms3000001993774108

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1187871, encodeId=cb29118e8717f, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220125/a0f139e590b8459ab0818b4c8db10d1e/720e8522d6f0409e9b33c4b968b59898.jpg, createdBy=c3b64856317, createdName=muxiaoqin28, createdTime=Tue Jan 25 00:12:18 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068245, encodeId=6605106824536, content=好平台 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d1786606, createdName=ms8456386680208506, createdTime=Mon Nov 08 20:26:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058843, encodeId=71e210588433d, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfd85517072, createdName=ms3000001993774108, createdTime=Sat Oct 09 10:01:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897843, encodeId=a91289e84328, content=实用指南,值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9665433008, createdName=ms2000001443379879, createdTime=Sun Nov 08 23:14:12 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2020-11-08 ms2000001443379879

    实用指南,值得学习。

    0

拓展阅读

2010ESMO临床实践指南:非上皮性卵巢癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01

2011 NICE 卵巢癌的诊断和起始治疗

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011 NICE Trabectedin治疗复发性卵巢癌

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2012 ESMO临床实践指南:非上皮性卵巢癌的诊治与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2012 NSGC实践指南:遗传性乳腺癌和卵巢癌的风险评估和遗传咨询

国家遗传咨询师学会(NSGC,National Society of Genetic Counselors) · 2012-11-28

2013 FIGO 卵巢癌、输卵管癌、腹膜癌分期指南

国际妇产科联盟(FIGO,International Federation of Gynecology and Obstetrics) · 2013-10-22